← SynDRA
SETIPTILINE
SynDRA canonical compound SYN0030884 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | HTR2C |
|---|
| Mechanism of action | Adrenergic receptor antagonist |
|---|
| Indication | depression |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HTR1A
- ADRA1A
- ADRA2A
- SLC6A4
- CHRM1
- CHRM2
- DRD1
- DRD3
- SLC6A2
- MAOA
- SLC6A3
- PTGS1
- PGR
- PDE4A
- PDE3A
- OPRM1
- ACHE
- KDR
- KCNH2
- HTR2B
- ADORA3
- HRH3
- HDAC6
- F2
- ESR1
- AR
- TBXA2R
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- tecipul
- Org-8282
- teciptilline
- setiptiline maleate
- Setiptilina
- ORG 8282
- Setiptilinum
- MO-8282
- 7L38105Z6E
- CHEBI:135076
- RefChem:182617
- DTXCID80128377
- Setiptiline [INN]
- Setiptiline (INN)
- Setiptilinum [Latin]
- Setiptilina [Spanish]
- EINECS 260-653-4
- BRN 1650422
- UNII-7L38105Z6E
- Tecipul [as maleate]
- SETIPTILINE [MI]
- SETIPTILINE [MART.]
- SETIPTILINE [WHO-DD]
- SCHEMBL211362
- orb1708532
- SCHEMBL29414110
- MSK11204
- EX-A11188
- MFCD00868385
- AKOS030526164
- CS-1181
- NCGC00378937-01
- NCGC00378937-02
- AC-37639
- DA-67551
- HY-32329
- MS-23683
- NS00053323
Look up SETIPTILINE in the interactive SynDRA portal →